1-[(2R,4R,5S)-4-Azido-5-(hydroxymethyl)oxolan-2-YL]-5-methyl-pyrimidine-2,4-dione
30516-87-1Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=OHBOMLICNUCNMMY-UHFFFAOYSA-NSee also: Zidovudine (annotation moved to).
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
解説エイズ(後天性免疫不全症候群)の治療薬。1960年代に制癌(せいがん)剤として開発された薬物。エイズの根本的治療薬とはならないが、臨床試験で延命効果が確認されている。AZT。小学館 デジタル大辞泉について 情報 | 凡例
用途薬理作用研究用。
用途抗AIDSウイルス薬
用途核酸アナログ逆転写酵素阻害 剤です。ヌクレオチドと構造が類似している ため、ウイルス DNA ポリメラーゼ / 逆転写 酵素による基質の取り込みを競合的に阻害 し、DNA 鎖の伸長を停止することによりウ イルス増殖阻害作用を示します。
用途核酸アナログ逆転写酵素阻害 剤です。ヌクレオチドと構造が類似している ため、ウィルス DNA ポリメラーゼ / 逆転写 酵素による基質の取り込みを競合的に阻害 し、DNA 鎖の伸長を停止することによりウィ ルスの増殖阻害作用を示します。
説明Zidovudine, also known as azidothymidine (AZT), is an antiviral agent acting via reverse transcnptase inhibition. It was first launched in the U.K. and subsequently introduced in over a dozen countries for the management of severe manifestations of HIV infection. In patients with AIDS and ARC, zidovudine reduces the risk of opportunistic infections and prolongs survival time. In symptom-free patients it shows promise in halting further immunological deterioration.
使用Zidovudine is an antiretroviral drug that is clinically active against HIV-1 and is intended to treat HIV-infected patients. Zidovudine is an analog of thymidine that inhibits replication of the AIDS virus. It also turned into mono-, di-, and triphosphates by the same cellular enzymes that catalyze phosphorylation of thymidine and thymidine nucleosides. Zidovudine-triphosphate is then included in the terminal fragment of the growing chain of viral DNA by viral reverse transcriptase, thus causing the viral DNA chain to break apart in cells infected with the virus. Zidovudine has been authorized for treating patients with AIDS. It significantly prolongs the life of the patient, although it has a number of toxic effects. Synonyms of this drug are azidothymidine and retrovir.
一般的な説明Zidovudine, 3'-azido-3'-deoxythymidine or AZT, is ananalog of thymidine that possesses antiviral activityagainst HIV-1, HIV-2, HTLV-1, and several other retroviruses.This nucleoside was synthesized in 1978 by Linand Prusoff as an intermediate in the preparation ofamino acid analogs of thymidine. A screening program directedtoward the identification of agents potentially effectivefor the treatment of patients with AIDS led to the discoveryof its unique antiviral properties 7 years later.Zidovudine is recommended for the management of adultpatients with symptomatic HIV infection (AIDS or ARC)who have a history of confirmed Pneumocystis carinii pneumoniaor an absolute CD4+(T4 or TH cell) lymphocytecount below 200/mm3 before therapy. The hematologicaltoxicity of the drug precludes its use in asymptomatic patients.Anemia and granulocytopenia are the most commontoxic effects associated with AZT.
30516-87-1化学的特性Needle-like crystals are obtained from petroleum ether and are odorless. They decompose upon exposure to light and are readily soluble in ethanol. Solubility in water at 25 °C: 25 mg/mL. Melting point: 106–112 °C (petroleum ether); a melting point of 120–122 °C (water) has also been reported. [α]D²³ +99° (c = 0.5, water). UV absorption maximum (water): 266.5 nm (ε = 11,650).Acute toxicity LD₅₀ values in male and female mice and rats (mg/kg) are 3,568, 3,062, 3,084, and 3,683, respectively. All values are greater than 750 mg/kg when administered orally or by subcutaneous injection.
定義ChEBI: Zidovudine is a pyrimidine 2',3'-dideoxyribonucleoside compound having a 3'-azido substituent and thymine as the nucleobase. It has a role as an antimetabolite, an antiviral drug and a HIV-1 reverse transcriptase inhibitor. It is an azide and a pyrimidine 2',3'-dideoxyribonucleoside.